FDA Revokes Clearance For Premature Birth Drug Makena
The U.S. Food and Drug Administration announced on Thursday that it would be pulling a medication intended to reduce the risk of preterm birth off the market after it found that...To view the full article, register now.
Already a subscriber? Click here to view full article